Opendata, web and dolomites

wellwatch

A hands-free remote monitoring solution for continuous and accurate medical grade assessment of heart health

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 wellwatch project word cloud

Explore the words cloud of the wellwatch project. It provides you a very rough idea of what is the project "wellwatch" about.

wearable    acceptable    cvd    initial    2021    80    gain    signals    provides    successful    assisting    validated    private    predictive    forecast    market    99bn    faster    follow    trip    preventable    time    innovation    disruptive    textile    hospital    historically    monitoring    feasibility    electronics    medically    centric    mover    cardiovascular    sensors    entry    4m    smartlife    9bn    projections    garment    first    platform    secure    chain    size    doctor    heart    disease    250    licensees    business    commercialisation    model    costly    route    advantage    25    self    annually    proposition    onset    clinically    health    snapshot    ec    transmits    estimates    patient    hospitals    death    worth    global    2019    remote    attractive    roi    contactless    premature    economically    diagnosis    supply    clinician    primary    smart    complete    wet    truly    wellwatch    prognosis    healthcare    suppliers    equates    770    ecg    electrocardiogram    12    consuming    mobile    hub    textiles    41tn    treatment    medical    care    save    solutions    patented    deaths   

Project "wellwatch" data sheet

The following table provides information about the project.

Coordinator
SMARTLIFEINC LIMITED 

Organization address
address: SANDERSON HOUSE STATION ROAD HORSFORTH
city: LEEDS
postcode: LS18 5NT
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.smartlifeinc.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SMARTLIFEINC LIMITED UK (LEEDS) coordinator 50˙000.00

Map

 Project objective

Cardiovascular disease (CVD) is the leading cause of death in the EU with over 4m deaths annually. Although up to 80% of premature deaths are preventable through early prognosis and treatment the associated costs are significant with global estimates of €41tn in the next 25 years. There is an increasing focus on making care more patient-centric which could save €99bn in healthcare costs in the EU annually.

Currently the only medically acceptable method of monitoring a CVD condition includes a trip to the hospital, a complete 12 lead ‘wet’ electrocardiogram (ECG) and a follow-up with a doctor. This process is time-consuming, costly to hospitals and provides only a snapshot of a patient’s heart health.

At Smartlife, we have developed wellwatch; a wearable technology garment with our patented textile sensors built in and our unique contactless electronics hub that transmits signals to a mobile application for remote monitoring by patient and clinician. Our technology can be truly disruptive – assisting in the diagnosis of early onset or predictive heart conditions.

To gain first mover advantage in the challenging medical market we must secure our supply chain, fully develop the care pathway and present an attractive value proposition to licensees and suppliers. We expect our initial route to market will be through private healthcare, as historically they have a faster uptake of novel solutions. The primary aim of our overall innovation project is to develop a clinically and economically validated wellwatch platform for self-monitoring of CVD. The objective of this feasibility study is to develop our business model for successful commercialisation of wellwatch.

The market size of smart textiles in medical applications is forecast to be worth €0.9bn by 2021; our growth projections for wellwatch are to achieve a 5-year ROI of 250% for Smartlife following market entry in 2019, based on our estimated project costs this equates to an ROI of 770% to the EC.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WELLWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "WELLWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

Leaf Line (2018)

The First Global Ground Station Network to Fully Exploit Microsatellites Data

Read More  

Meshporto_smeIns1_2 (2018)

PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.

Read More